We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$16.6M
AUM Growth
-$9.9B
(-100%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-776.34%
Top 10 Holdings %
Top 10 Hldgs %
44.31%
Holding
282
New
27
Increased
109
Reduced
88
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$68M |
| 2 |
eBay
EBAY
|
+$60.2M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$55.9M |
| 4 |
Cognizant
CTSH
|
+$54.2M |
| 5 |
SS&C Technologies
SSNC
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$56.6M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$49.2M |
| 3 |
Elevance Health
ELV
|
+$44.3M |
| 4 |
Apple
AAPL
|
+$41.2M |
| 5 |
Abbott
ABT
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.69% |
| 2 | Financials | 13.93% |
| 3 | Healthcare | 11.89% |
| 4 | Communication Services | 7.22% |
| 5 | Industrials | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Aflac
AFL
$64.3B
| $18.9K | 0.11% |
440,000
-28,500
| -6% | -$1.28M |
|
|
PRA
152
DELISTED
ProAssurance
PRA
| $18.6K | 0.11% |
525,000
+137,500
| +35% | +$5.75M |
|
|
GG
153
DELISTED
Goldcorp Inc
GG
| $18.3K | 0.11% |
1,335,451
+686,926
| +106% | +$9.54M |
|
154
Ferrari
RACE
$66.4B
| $18.2K | 0.11% |
+156,326
| New | +$20.5M |
|
155
Danaher
DHR
$137B
| $18K | 0.11% |
205,928
| – | – |
|
156
Toronto Dominion Bank
TD
$197B
| $17.8K | 0.11% |
234,397
-1,463
| -0.6% | -$83.7K |
|
|
157
Merck
MRK
$324B
| $17.8K | 0.11% |
306,540
-1,003,460
| -77% | -$56.6M |
|
158
Jazz Pharmaceuticals
JAZZ
$15.9B
| $17.2K | 0.1% |
100,000
+40,000
| +67% | +$6.54M |
|
159
Insulet
PODD
$11.5B
| $17.1K | 0.1% |
200,000
-159,946
| -44% | -$14.3M |
|
|
AVEO
160
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $17.1K | 0.1% |
755,267
-32,476
| -4% | -$770K |
|
|
CBIO
161
Crescent Biopharma
CBIO
$637M
| $16.9K | 0.1% |
10,476
+185
| +2% | +$318K |
|
162
UBS Group
UBS
$171B
| $16.4K | 0.1% |
1,072,414
| – | – |
|
|
XLRN
163
DELISTED
Acceleron Pharma
XLRN
| $15.7K | 0.09% |
324,185
-748,713
| -70% | -$27.3M |
|
164
Supernus Pharmaceuticals
SUPN
$2.76B
| $15K | 0.09% |
250,000
-25,000
| -9% | -$1.3M |
|
165
Manchester United
MANU
$3.96B
| $14.7K | 0.09% |
714,835
| – | – |
|
166
Aurinia Pharmaceuticals
AUPH
$1.99B
| $14.6K | 0.09% |
2,600,200
+100,200
| +4% | +$559K |
|
|
AZPN
167
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $14.5K | 0.09% |
156,140
-85,401
| -35% | -$7.92K |
|
168
Regeneron Pharmaceuticals
REGN
$70.5B
| $13.8K | 0.08% |
40,000
+2,500
| +7% | +$782K |
|
169
Gilead Sciences
GILD
$163B
| $13.5K | 0.08% |
191,000
+41,000
| +27% | +$2.9M |
|
170
PNC Financial Services
PNC
$99.3B
| $13.4K | 0.08% |
99,488
-4,305
| -4% | -$628K |
|
171
Axogen
AXGN
$2.18B
| $13.1K | 0.08% |
+260,290
| New | +$11.5M |
|
172
Agnico Eagle Mines
AEM
$72.6B
| $13.1K | 0.08% |
+285,381
| New | +$12.6M |
|
173
Littelfuse
LFUS
$10B
| $12.8K | 0.08% |
56,127
+2,773
| +5% | +$595K |
|
174
Ares Capital
ARCC
$13.6B
| $12K | 0.07% |
731,732
| – | – |
|
175
Revvity
RVTY
$12B
| $12K | 0.07% |
164,000
+22,113
| +16% | +$1.66M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Polar Capital held 282 positions worth $16.6M, down 100% from $9.92B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Polar Capital withdrew a net $129M in Q2 2018, closing 26 positions and reducing 88 holdings. Its most notable exit was GCI Liberty, Inc. Class A Common Stock (DE), an estimated $37.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Polar Capital opened a new position in Cognizant worth $54.4K.
- Polar Capital's largest Q2 2018 buy was Cognizant: 688,687 shares worth $54.4K.
- Polar Capital added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2018, an estimated $68M increase.
- Polar Capital's biggest Q2 2018 reduction was Merck, cutting an estimated $56.6M.
- Polar Capital fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q2 2018, selling an estimated $37.7M.
- Polar Capital's ten largest holdings make up 44% of its $16.6M portfolio in Q2 2018.
- Polar Capital opened 27 new positions and closed 26 in Q2 2018.
- Polar Capital's portfolio value fell 100% quarter-over-quarter to $16.6M.
Based on Polar Capital's 13F filing for Q2 2018, filed 14 Aug 2018.